AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $765.77 million. The enterprise value is $2.79 billion.
| Market Cap | 765.77M |
| Enterprise Value | 2.79B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 133.41 million shares outstanding. The number of shares has increased by 0.40% in one year.
| Current Share Class | 133.41M |
| Shares Outstanding | 133.41M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 8.42% |
| Owned by Institutions (%) | 81.51% |
| Float | 85.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.23 |
| Forward PS | 0.26 |
| PB Ratio | 0.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.78 |
| P/OCF Ratio | 1.30 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.00, with an EV/FCF ratio of 28.48.
| EV / Earnings | n/a |
| EV / Sales | 0.83 |
| EV / EBITDA | 10.00 |
| EV / EBIT | n/a |
| EV / FCF | 28.48 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.49.
| Current Ratio | 1.12 |
| Quick Ratio | 0.64 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | 7.43 |
| Debt / FCF | 21.14 |
| Interest Coverage | -1.42 |
Financial Efficiency
Return on equity (ROE) is -15.22% and return on invested capital (ROIC) is 4.61%.
| Return on Equity (ROE) | -15.22% |
| Return on Assets (ROA) | 2.28% |
| Return on Invested Capital (ROIC) | 4.61% |
| Return on Capital Employed (ROCE) | -3.96% |
| Weighted Average Cost of Capital (WACC) | 6.15% |
| Revenue Per Employee | $308,568 |
| Profits Per Employee | -$20,881 |
| Employee Count | 10,900 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 21.38 |
Taxes
| Income Tax | -7.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.04% in the last 52 weeks. The beta is 1.46, so AdaptHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -40.04% |
| 50-Day Moving Average | 9.61 |
| 200-Day Moving Average | 10.28 |
| Relative Strength Index (RSI) | 23.21 |
| Average Volume (20 Days) | 3,873,780 |
Short Selling Information
The latest short interest is 8.07 million, so 6.05% of the outstanding shares have been sold short.
| Short Interest | 8.07M |
| Short Previous Month | 8.01M |
| Short % of Shares Out | 6.05% |
| Short % of Float | 9.41% |
| Short Ratio (days to cover) | 7.59 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.36 billion and -$227.60 million in losses. Loss per share was -$1.68.
| Revenue | 3.36B |
| Gross Profit | 644.93M |
| Operating Income | 158.50M |
| Pretax Income | -234.68M |
| Net Income | -227.60M |
| EBITDA | 278.13M |
| EBIT | -143.86M |
| Loss Per Share | -$1.68 |
Balance Sheet
The company has $43.29 million in cash and $2.07 billion in debt, with a net cash position of -$2.02 billion or -$15.15 per share.
| Cash & Cash Equivalents | 43.29M |
| Total Debt | 2.07B |
| Net Cash | -2.02B |
| Net Cash Per Share | -$15.15 |
| Equity (Book Value) | 1.39B |
| Book Value Per Share | 10.34 |
| Working Capital | 88.26M |
Cash Flow
In the last 12 months, operating cash flow was $583.27 million and capital expenditures -$485.59 million, giving a free cash flow of $97.68 million.
| Operating Cash Flow | 583.27M |
| Capital Expenditures | -485.59M |
| Depreciation & Amortization | 424.97M |
| Net Borrowing | 56.75M |
| Free Cash Flow | 97.68M |
| FCF Per Share | $0.73 |
Margins
Gross margin is 19.18%, with operating and profit margins of 4.71% and -6.79%.
| Gross Margin | 19.18% |
| Operating Margin | 4.71% |
| Pretax Margin | -6.98% |
| Profit Margin | -6.79% |
| EBITDA Margin | 8.62% |
| EBIT Margin | -4.46% |
| FCF Margin | 2.90% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.40% |
| Shareholder Yield | -0.40% |
| Earnings Yield | -29.93% |
| FCF Yield | 12.85% |
Analyst Forecast
The average price target for AdaptHealth is $9.14, which is 59.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.14 |
| Price Target Difference | 59.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -1.15% |
| EPS Growth Forecast (3Y) | -79.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 0.94 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.94 |
| Piotroski F-Score | 5 |